Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMBR | P28336 | 1/20 | 0.42 |
| ▸ | SIRT2 | Q8IXJ6 | 12/20 | 0.41 |
| ▸ | CTSS | P25774 | 3/20 | 0.38 |
| ▸ | CTSK | P43235 | 2/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30384919 | 0.92 | SIRT2 (0.44) | NMBRSIRT2CTSSCTSKCTSL | |
| SCHEMBL30665993 | 0.91 | NMBR (0.44) | NMBRSIRT2CTSSCTSKCTSL | |
| SCHEMBL30384691 | 0.90 | NMBR (0.40) | NMBRSIRT2 | |
| SCHEMBL30277394 | 0.89 | NMBR (0.44) | NMBRSIRT2CTSS | |
| SCHEMBL29427178 | 0.88 | NMBR (0.51) | NMBRSIRT2CTSSCTSKCTSL | |
| SCHEMBL29427176 | 0.88 | NMBR (0.51) | NMBRSIRT2CTSSCTSKCTSL | |
| SCHEMBL12981253 | 0.86 | CTSS (0.35) | CTSSCTSKCTSLCTSB | |
| SCHEMBL31614316 | 0.84 | NMBR (0.38) | NMBRSIRT2 | |
| SCHEMBL18367552 | 0.83 | SIRT2 (0.49) | NMBRSIRT2CTSSCTSKCTSL | |
| SCHEMBL30120772 | 0.83 | SIRT2 (0.49) | NMBRSIRT2CTSSCTSKCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119080911-B | Semex lattice Synthesis method of lupeptide | 中肽生化有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119080911-A | Semex lattice Synthesis method of lupeptide | 中肽生化有限公司 | 2024-12-06 | — | — | CN | claimed |
| US-20230220036-A1 | IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | NEULAND LABORATORIES LTD (IN) | 2023-07-13 | — | — | US | claimed |
| EP-4146249-A1 | IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | Neuland Laboratories Ltd (IN) | 2023-03-15 | — | — | EP | claimed |
| CN-119080911-B | Semex lattice Synthesis method of lupeptide | 中肽生化有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119080911-A | Semex lattice Synthesis method of lupeptide | 中肽生化有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-116693653-B | Preparation method for large-scale production of somalupeptide | 杭州湃肽生化科技有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116693653-A | Preparation method for large-scale production of somalupeptide | 杭州湃肽生化科技有限公司 | 2023-09-05 | — | — | CN | disclosed |
| US-20230220036-A1 | IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | NEULAND LABORATORIES LTD (IN) | 2023-07-13 | — | — | US | disclosed |
| EP-4146249-A1 | IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | Neuland Laboratories Ltd (IN) | 2023-03-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220036-A1 | IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | GCG, OGDH, ABAT | NMBR 1574/4885SIRT2 3006/4885CTSS 1837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.